These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 4393781
1. The metabolism in vitro and hepatic microsomal interactions of some enantiomeric drug substrates. Hewick DS, Fouts JR. Biochem J; 1970 May; 117(5):833-41. PubMed ID: 4393781 [Abstract] [Full Text] [Related]
2. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450. Di Augustine RP, Fouts JR. Biochem J; 1969 Nov; 115(3):547-54. PubMed ID: 4390924 [Abstract] [Full Text] [Related]
4. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation. Lu AY, Strobel HW, Coon MJ. Biochem Biophys Res Commun; 1969 Aug 15; 36(4):545-51. PubMed ID: 4390187 [No Abstract] [Full Text] [Related]
6. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats. Jeffery EH, Mannering GJ. Mol Pharmacol; 1983 May 15; 23(3):748-57. PubMed ID: 6865917 [Abstract] [Full Text] [Related]
7. Substrate binding site of microsomal cytochrome P-450 directly faces membrane lipids. Taniguchi H, Imai Y, Sato R. Biochem Biophys Res Commun; 1984 Feb 14; 118(3):916-22. PubMed ID: 6704114 [Abstract] [Full Text] [Related]
8. The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) in vitro in rat. Inoue T, Suzuki S, Niwaguchi T. Xenobiotica; 1983 Apr 14; 13(4):241-9. PubMed ID: 6624139 [Abstract] [Full Text] [Related]
9. [Stoichiometry of microsomal oxidation reactions. Distribution of redox-equivalents in monooxygenase and oxidase reactions catalyzed by cytochrome P-450]. Zhukov AA, Archakov AI. Biokhimiia; 1985 Dec 14; 50(12):1939-52. PubMed ID: 4074780 [Abstract] [Full Text] [Related]
10. Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes. Brady JF, Di Stefano EW, Cho AK. Life Sci; 1986 Oct 20; 39(16):1457-64. PubMed ID: 2877380 [Abstract] [Full Text] [Related]
11. Organic solvent extraction of liver microsomal lipid. Effect on the kinetic parameters of benzo[a]pyrene hydroxylase and benzphetamine N-demethylase activity. Vore M, Soliven E. Biochem Pharmacol; 1979 Dec 15; 28(24):3659-65. PubMed ID: 533563 [No Abstract] [Full Text] [Related]
12. The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines. Franklin MR. Drug Metab Dispos; 1974 Dec 15; 2(3):321-6. PubMed ID: 4153124 [No Abstract] [Full Text] [Related]
13. In vivo and in vitro effect of chelating agents on drug metabolizing enzymes of the rat. Dalvi RR, McGowan C, Ademoyero A. Toxicol Lett; 1980 Jun 15; 6(1):25-8. PubMed ID: 7423540 [Abstract] [Full Text] [Related]
14. Kinetics of reduction of purified liver microsomal cytochrome P-450 in the reconstituted enzyme system studied by stopped flow spectrophotometry. Vatsis KP, Oprian DD, Coon MJ. Acta Biol Med Ger; 1979 Jun 15; 38(2-3):459-73. PubMed ID: 42251 [Abstract] [Full Text] [Related]
15. Metabolism of diet pill to amphetamine and methamphetamine. Teter DF. J Occup Environ Med; 1999 Mar 15; 41(3):139. PubMed ID: 10091135 [No Abstract] [Full Text] [Related]
16. Reduction and catalytic properties of cytochrome P-450 LM2 in reconstituted system containing monomeric carriers. Kanaeva IP, Skotselyas ED, Turkina IF, Petrochenko EV, Davydov DR, Kondrashin SK, Dzuzenova ChS, Bachmanova GI, Archakov AI. Biochem Biophys Res Commun; 1987 Sep 30; 147(3):1295-9. PubMed ID: 3663218 [Abstract] [Full Text] [Related]
17. A study of some possible mechanisms by which magnesium activates hepatic microsomal drug metabolism in vitro. Peters MA, Fouts JR. J Pharmacol Exp Ther; 1970 Jun 30; 173(2):233-41. PubMed ID: 4393573 [No Abstract] [Full Text] [Related]
18. Correlation between anorectic potency and affinity for hypothalamic (+)-amphetamine binding sites of phenylethylamines. Blosser JC, Barrantes M, Parker RB. Eur J Pharmacol; 1987 Jan 28; 134(1):97-103. PubMed ID: 3556402 [Abstract] [Full Text] [Related]
19. Role of phospholipid in the reconstituted liver microsomal mixed function oxidase system containing cytochrome P-450 and NADPH-cytochrome P-450 reductase. Autor AP, Kaschnitz RM, Heidema JK, Van der Hoeven TA, Duppel W, Coon MJ. Drug Metab Dispos; 1973 Jan 28; 1(1):156-61. PubMed ID: 4149377 [No Abstract] [Full Text] [Related]
20. Correlations between spin equilibrium shift, reduction rate, and N-demethylation activity in liver microsomal cytochrome P-450 and a series of benzphetamine analogues as substrates. Blanck J, Rein H, Sommer M, Ristau O, Smettan G, Ruckpaul K. Biochem Pharmacol; 1983 Jun 01; 32(11):1683-8. PubMed ID: 6870907 [Abstract] [Full Text] [Related] Page: [Next] [New Search]